RxSight (RXST) Change in Acquisitions & Divestments (2020 - 2025)
Historic Change in Acquisitions & Divestments for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $60.0 million.
- RxSight's Change in Acquisitions & Divestments fell 1304.35% to $60.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $225.0 million, marking a year-over-year decrease of 546.22%. This contributed to the annual value of $243.0 million for FY2024, which is 470.59% down from last year.
- According to the latest figures from Q3 2025, RxSight's Change in Acquisitions & Divestments is $60.0 million, which was down 1304.35% from $50.0 million recorded in Q2 2025.
- Over the past 5 years, RxSight's Change in Acquisitions & Divestments peaked at $90.0 million during Q1 2022, and registered a low of $15.0 million during Q3 2021.
- Moreover, its 5-year median value for Change in Acquisitions & Divestments was $55.0 million (2023), whereas its average is $52.8 million.
- Per our database at Business Quant, RxSight's Change in Acquisitions & Divestments surged by 40000.0% in 2022 and then tumbled by 3333.33% in 2023.
- Quarter analysis of 5 years shows RxSight's Change in Acquisitions & Divestments stood at $25.0 million in 2021, then soared by 80.0% to $45.0 million in 2022, then increased by 11.11% to $50.0 million in 2023, then increased by 10.0% to $55.0 million in 2024, then rose by 9.09% to $60.0 million in 2025.
- Its Change in Acquisitions & Divestments stands at $60.0 million for Q3 2025, versus $50.0 million for Q2 2025 and $60.0 million for Q1 2025.